Ahead of print 03 Feb 2023
English
 
Ischemic heart disease
Performance analysis of a STEMI network: prognostic impact of the type of first medical contact facility
Oriol de Diego [...], Cosme García-García
01 Feb 2023 10.1016/j.rec.2022.12.010
Site of first medical contact and mortality in STEMI. Insights for optimizing STEMI network
 
Editorial
Stand-alone surgery for atrial fibrillation
Manuel Carnero-Alcázar [...], Juan José González-Ferrer
30 Ene 2023 10.1016/j.rec.2022.10.018
Surgical ablation as a therapeutic option in patients with atrial fibrillation
 
Comment on the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
30 Ene 2023 10.1016/j.rec.2022.11.008
 
Arrythmias and cardiac stimulation
New research avenues for the prognostic value of the Tpeak-Tend interval in patients with different morphological variants of tako-tsubo syndrome
John E. Madias
30 Ene 2023 10.1016/j.rec.2022.12.012
 
Interventional cardiology
Initial experience with the coronary sinus reducer for the treatment of refractory angina in Spain
Oriol Rodríguez-Leor [...], Saleta Fernández
30 Ene 2023 10.1016/j.rec.2022.10.012
Coronary sinus reducer for refractory angina: a new option for treatment
 
Trillium: a new treatment for severe tricuspid regurgitation
Ignacio Cruz-González [...], Sergio López-Tejero
26 Ene 2023 10.1016/j.rec.2022.12.008
 
Cardiomyopathy and heart failure
Mid-ventricular obstruction in hypertrophic cardiomyopathy: a signal void
Mariana Brandão [...], Iacopo Olivotto
30 Ene 2023 10.1016/j.rec.2022.12.009
 
Epidemiology, risk factors and prevention
Extremely low high-density lipoproteins and corneal opacities
Julia Costas Eimil, Paula Sánchez-Sobrino
31 Ene 2023 10.1016/j.rec.2022.11.012
 
Español
 
Miocardiopatías e insuficiencia cardiaca
CANDI: clortalidona frente a acetazolamida en pacientes con resistencia diurética e insuficiencia cardiaca aguda
Paula Vela Martín [...], Marta Cobo Marcos
31 Ene 2023 10.1016/j.recesp.2022.11.009
¿Clortalidona o acetazolamida en pacientes con resistencia a los diuréticos?
 
Ver más articles in press
Check for more articles in press
REC: CardioClinics
REC: CardioClinics is a journal from REC Publications, the family of scientific publications of the Spanish Society of Cardiology (SEC), that covers the study, prevention and management of clinical cardiovascular medicine. This quarterly journal publishes articles in their language of reception (Spanish or English) and is indexed in ScienceDirect, Scopus, Latindex Embase and Dialnet.
REC: Interventional Cardiology
REC: Interventional Cardiology is the official publication of the of the Interventional Cardiology Association at the Spanish Society of Cardiology (ACI-SEC) of the Spanish Society of Cardiology (SEC). This quarterly bilingual English-Spanish journal is part of REC Publications and offers full open access. It is indexed in DOAJ, Dialnet, Scopus and Latindex.
Manage your account and subscriptions Share
Cancel subscription | Privacy policy

ELSEVIER ESPAÑA S.L.U reserves all rights granted by current legislation.

You can exercise your rights of access, rectification or cancellation of data by going to atencionalcliente@elsevier.com.

You only can send or copy this document without making any changes, not for commercial purposes, you must include the copyright notice, also include the internet source address https://www.revespcardiol.org/

Sociedad Española de Cardiología
Ntra. Sra. de Guadalupe 5. 28028 Madrid, España
Tel. 34 917 242 370
(c) Copyright 1997 - 2023 Sociedad Española de Cardiología